The Clinician-Administered PTSD Scale (CAPS) is widely recognized as the gold standard for diagnosing and assessing Post-Traumatic Stress Disorder (PTSD). This structured interview helps therapists evaluate how trauma shows up in daily life, from symptom intensity and frequency to real-world impact.

In this guide, we’ll unpack how CAPS works, what makes it so reliable, and how to use the latest CAPS-5 version for more accurate, defensible diagnoses.

If you regularly assess trauma or monitor symptom changes, Mentalyc’s Progress Tracking helps you visualize patterns and improvements across sessions, turning your notes into clear, data-backed insight on client recovery. For the underlying methods, see our guides to symptom trend tracking and outcome measures in mental health.

What is the Clinician-Administered PTSD Scale (CAPS)?

The CAPS is a structured interview that determines whether a person meets the DSM-5 diagnostic threshold for PTSD, while at the same time measuring symptom severity and functional impairment. First designed for diagnosing PTSD, the CAPS is a special tool used for appraising the prevalence, frequency, and intensity of symptoms among traumatized individuals. As a gold standard in diagnosing PTSD, it ensures that each symptom meets the criteria laid down in intrusiveness, avoidance, negative alteration of mood and cognition, and heightened arousal presented by the DSM-5.

Developed by the U.S. Department of Veterans Affairs National Center for PTSD, CAPS has been refined over time to stay current with the Diagnostic and Statistical Manual of Mental Disorders (DSM). It was modeled in part on the clinician-administered format of the Hamilton Depression Rating Scale, and the latest version, CAPS-5, aligns with the DSM-5 criteria. Clinically, CAPS is used to aid in treatment decisions by monitoring changes in symptoms or assessing the effectiveness of interventions. It further plays an important role in research, military, and forensic settings by providing reliable data on the prevalence of PTSD, treatment outcomes, and disability claims, and it is used widely through the VA for compensation and pension determinations. Because CAPS captures both qualitative and quantitative aspects of PTSD, it provides a comprehensive and evidence-based assessment (Lee et al., 2022).

How many items are on the CAPS-5?

The CAPS-5 is a 30-item structured interview. Twenty of those items correspond to the 20 DSM-5 PTSD symptoms, and the remaining ten cover the onset and duration of symptoms, subjective distress, the impact of symptoms on social and occupational functioning, improvement since any previous CAPS administration, overall response validity, overall PTSD severity, and the dissociative subtype (depersonalization and derealization).

Administration also requires identifying a single index traumatic event to anchor the symptom inquiry. The Life Events Checklist for DSM-5 (LEC-5) is recommended for this, in addition to the Criterion A inquiry built into the CAPS-5.

What is the structure of the CAPS-5?

The CAPS-5 mirrors the DSM-5 symptom criteria for PTSD, organized into four primary symptom clusters.

The specific symptoms assessed within each cluster begin with intrusion (items 1 to 5): unwanted memories, nightmares, flashbacks, feeling upset when reminded of the trauma, and physical reactions to reminders. Avoidance (items 6 to 7) covers avoiding thoughts or feelings about the trauma and avoiding people, places, or things that bring up memories. Negative changes in thoughts and mood (items 8 to 14) include trouble remembering parts of the trauma, negative beliefs about self, others, or the world, blaming self or others, ongoing negative emotions, less interest in activities, feeling distant from others, and trouble feeling positive emotions. Finally, changes in arousal and reactivity (items 15 to 20) cover irritability and anger, risky behavior, being overly watchful, being easily startled, problems concentrating, and sleep problems. The interview also captures when symptoms started, how they affect daily life, and checks for the dissociative subtype (items 19 and 20).

How is the CAPS-5 scored?

For each of the 20 symptoms, the clinician combines information about frequency and intensity into a single severity rating on a 0 to 4 scale. A 0 means the symptom is absent, where the respondent denied the problem or the report does not fit the DSM-5 criterion. A 1 is mild or subthreshold, consistent with the criterion but not clinically significant and not counting toward diagnosis. A 2 is moderate or threshold, a clinically significant problem that satisfies the criterion and would be a target for intervention, which requires a minimum frequency of about twice a month (or 20 to 30 percent of the time) plus an intensity that is clearly present. A 3 is severe or markedly elevated, above threshold, difficult to manage, and a prominent intervention target, which requires a minimum frequency of about twice a week (or 50 to 60 percent of the time) plus a pronounced intensity. A 4 is extreme or incapacitating, dramatic, pervasive, and overwhelming, and a high-priority target.

The total symptom severity score is the sum of the 20 individual severity scores, ranging from 0 to 80, with higher scores indicating greater severity. Cluster severity scores are calculated by summing the items within each DSM-5 criterion: Criterion B (items 1 to 5), Criterion C (items 6 to 7), Criterion D (items 8 to 14), and Criterion E (items 15 to 20). A dissociation score can be derived by summing items 19 and 20.

What CAPS-5 score indicates PTSD?

A PTSD diagnosis is not based on the total score alone, because it requires meeting the DSM-5 symptom algorithm. Using the moderate-or-higher threshold (a rating of 2 or above) per symptom, a respondent must show at least one Criterion B (intrusion) symptom, at least one Criterion C (avoidance) symptom, at least two Criterion D (negative cognition and mood) symptoms, and at least two Criterion E (arousal and reactivity) symptoms. In addition, Criterion F must be met, meaning the disturbance has lasted at least one month, and Criterion G must be met, meaning the disturbance causes clinically significant distress or functional impairment.

What CAPS-5 score indicates improvement?

Evidence for clinically meaningful change is still developing, but two benchmarks are commonly cited. A drop of about 10 points is suggested as an indicator of treatment response (Schnurr et al., 2022). One study found a CAPS-5 total below 8 can indicate clinically significant change, placing the respondent in the non-disordered population (Marx et al., 2022), though a diagnosis itself cannot be made with a score under 12, so a score under 12 is generally treated as indicative of remission. Re-administering the CAPS-5 over time lets clinicians track these shifts, as falling scores show what is working while persistent scores flag what needs more attention.

What is the difference between CAPS-5 and the older CAPS (CAPS-IV)?

The CAPS began in the early 1990s with Blake, Weathers, and colleagues, who needed a standardized way for all clinicians to diagnose PTSD the same way. The biggest update came with DSM-5, producing the CAPS-5 (Weathers, Blake, Schnurr, Kaloupek, Marx, and Keane, 2013).

The earlier DSM-IV version assessed 17 core PTSD symptoms across 30 items, plus 5 associated symptoms: guilt about actions during the trauma, survivor’s guilt, decreased environmental awareness, derealization, and depersonalization. It used two separate ratings, frequency and intensity, each on a 0 to 4 scale, and two rules for deciding whether a symptom was present. Under the lenient rule, a symptom counted if rated at least 1 for frequency and 2 for intensity. Under the stringent rule, a symptom counted if frequency plus intensity totaled 4 or higher. Total severity scores ranged from 0 to 136, with scores above 65 typically indicating PTSD.

CAPS-5 simplified this by focusing on one traumatic event instead of three, using 30 items matched to DSM-5 criteria, adding the dissociative subtype, and replacing the two-part rating with a single combined 0 to 4 severity score for a total of 0 to 80. More recently, the CAPS-5-R refined the assessment with expanded prompts and scoring guidelines, a more granular 0 to 10 severity scale, a frequency response card to help respondents report symptoms, and improved formatting, enhancing reliability and validity while staying compatible with CAPS-5 for longitudinal research.

The naming has tracked each DSM revision. Under DSM-III-R the versions were labeled CAPS-1 (one-month and lifetime) and CAPS-2 (one-week); under DSM-IV these became CAPS-DX and CAPS-SX, with a CAPS-CA for children; and under DSM-5 all timeframes consolidated under the single CAPS-5 name, alongside the CAPS-CA-5 for children and adolescents.

How long does the CAPS-5 take, and who can administer it?

The full interview takes 45 to 60 minutes. It was designed for clinicians and clinical researchers with a working knowledge of PTSD, such as psychologists, psychiatrists, and licensed mental health clinicians, but can also be administered by appropriately trained paraprofessionals. Because it is not a self-report tool, formal training in structured clinical interviewing, differential diagnosis, and the CAPS-5’s own conventions is strongly encouraged.

For younger patients, a developmentally appropriate version, the CAPS-CA-5, is available for children and adolescents ages 7 to 17. For broader pediatric screening, our trauma symptom checklist for children covers complementary tools.

How is the CAPS-5 administered?

The CAPS-5 is administered as a standardized 45 to 60 minute interview in which the clinician identifies one index trauma, then asks set questions and probes for each symptom and assigns a severity rating. In practice, the clinician first explains the purpose and builds rapport, then identifies the single most distressing traumatic event using the Life Events Checklist or direct questions. For each symptom, the clinician asks standardized questions and follow-up probes. When asking about unwanted memories, for example, the clinician might ask whether the person has had any unwanted memories of the event while awake, how those memories come to them, how much they bother them, whether they can be put out of mind, and how often they happen in the past month.

The interview balances structure with flexibility, because the main questions stay fixed while follow-ups adapt to the responses, which keeps the data accurate while remaining sensitive to the person’s experience. Clinicians should be supportive but neutral, acknowledging how hard it is to talk about trauma while avoiding leading questions.

The CAPS-5 comes in three versions by timeframe: past week, past month, and worst month (lifetime). The past-month version is most common for current diagnosis, and the worst-month or lifetime version helps map history. The past-week version should be used only to evaluate symptoms over the past week, not to establish diagnostic status.

Who uses the CAPS?

The main users are mental health professionals, researchers, forensic professionals, and clinical-trial investigators. Psychologists, psychiatrists, and licensed clinicians use it to diagnose PTSD and build treatment plans. Researchers rely on its detail to study PTSD prevalence, treatment effectiveness, and the neurological effects of trauma. Clinicians in VA settings and forensic experts apply it in disability assessments and legal cases, and trial investigators use it to set baseline severity and monitor symptom change over time.

How is the CAPS used in diagnosis and treatment planning?

The CAPS-5 does more than diagnose, because it also guides treatment. For diagnosis, it confirms PTSD against DSM-5 criteria, distinguishes PTSD from similar conditions like depression or anxiety, and identifies the dissociative subtype when present.

For treatment planning, it shows which specific symptoms need the most attention, helps prioritize targets by severity, and reveals how PTSD affects different areas of life. If the assessment shows severe nightmares and hypervigilance but mild avoidance, for instance, treatment might focus first on sleep problems and reducing the constant sense of danger, and a structured mental health treatment plan can then formalize these targets. Re-administering during treatment tracks progress, and the results help communicate the diagnosis and needs to other providers and insurers.

Many therapists streamline this workflow with digital tools. Mentalyc’s AI Progress Tracker turns assessment results into measurable outcomes across sessions, so the symptom clusters identified in the CAPS can be monitored over time rather than re-scored from memory.

What are the benefits of the CAPS over self-report tools?

While questionnaires are convenient, the CAPS-5 interview offers advantages a checklist cannot. It brings in clinical judgment, so the interviewer can distinguish similar but distinct problems, such as trauma-specific nightmares versus general bad dreams. The format allows deeper symptom understanding, exploring exactly what a person avoids and how it affects their life. It enables accuracy checks, since the clinician can assess whether symptoms are over- or under-reported based on behavior and consistency. It captures context, including when symptoms happen, what triggers them, and how they relate to the trauma. It supports relationship-building, because the process itself can build trust and begin the therapeutic alliance. And it improves differential diagnosis, since what looks like emotional numbness on a questionnaire might actually be depression or a medication effect.

These strengths are also why CAPS shows high inter-rater reliability, strong convergent validity with measures like the PTSD Checklist (PCL-5), and predictive validity for future symptom severity and functional impairment, which is why it is routinely used as the diagnostic anchor in randomized PTSD treatment trials (Possemato et al., 2023). Trauma-informed CBT is one such evidence-based approach often evaluated this way.

What are the limitations of the CAPS?

Despite its strengths, the CAPS-5 has real constraints. The biggest is time, since a full interview takes 45 to 60 minutes, far longer than a questionnaire, which is hard in busy settings and makes it unsuitable for routine screening. It requires training, because proper use and interpretation depend on trained clinicians, making it less accessible than self-report measures like the PCL-5. It carries some subjectivity, since scoring relies on clinician judgment and some variance between assessors is possible. It can affect patient comfort, as the intensive interview can be distressing for some survivors and requires a trauma-informed approach to avoid retraumatization. It anchors to a single index trauma, assessing one Criterion A event at a time, which can be limiting for clients with multiple traumas. And it is narrow in scope, because focusing only on PTSD can miss other issues, while some culturally specific trauma responses may not be fully captured. It is also worth noting that the CAPS was originally constructed using data from military veterans, so although it is widely used in non-veteran populations, there may be differences in how trauma presents across groups.

Used appropriately, and as part of a broader assessment, the CAPS-5 remains invaluable for understanding the severity and impact of PTSD and guiding treatment.

Mentalyc: Smart Documentation for Trauma-Focused Care

Mentalyc is a Clinical Intelligence platform that supports trauma-focused care by automatically capturing symptom trends and progress across sessions, connecting what is said in session to measurable outcomes and keeping documentation accurate, compliant, and clinically meaningful. Its AI Note Taker turns voice or written input into clear, compliant notes, letting clinicians focus on compassionate, evidence-based care. Its AI Progress Tracker follows goal progress and symptom-severity fluctuations across sessions, the AI Treatment Planner turns assessment findings into structured, payor-ready plans, and Alliance Genie surfaces therapeutic-alliance insights from each session.

Monthly billing is also available at a higher per-month rate, and group-practice pricing is offered separately on the group practice plan.

Frequently Asked Questions About the Clinician-Administered PTSD Scale (CAPS)

References

Weathers, F. W., Blake, D. D., Schnurr, P. P., Kaloupek, D. G., Marx, B. P., & Keane, T. M. (2013). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). U.S. Department of Veterans Affairs, National Center for PTSD.

Marx, B. P., Lee, D. J., Norman, S. B., Bovin, M. J., Sloan, D. M., Weathers, F. W., Keane, T. M., & Schnurr, P. P. (2022). Reliable and clinically significant change in the CAPS-5 and PCL-5 among male Veterans. Psychological Assessment, 34(2), 197 to 203.

Schnurr, P. P., et al. (2022). Comparison of Prolonged Exposure vs Cognitive Processing Therapy for treatment of PTSD among US Veterans. JAMA Network Open, 5(1), e2136921.

Lee et al. (2022); Possemato et al. (2023); Rivest-Beauregard et al. (2022).

Ready to start your free trial?

15 free notes for 14 days • No credit card required

Try for FREE View Pricing

Why other mental health professionals love Mentalyc

“It improves the quality of my work as I review my sessions … I bring a sense of continuity from session to session because of the really good summary and progress notes that Mentalyc gives me.”

“I go back and can read the notes, and it really helps me for the next session. It has made me a much better counselor.”

“It helps align the note and the plan for moving forward with sessions … it’s been a really good aid in giving me direction.”

“I benefit tremendously every time I wrap up a session and then a few minutes later, I have this AI note. It makes me a better clinician in a variety of ways.”